← FDA Drug Approvals (Drugs@FDA)

PREGABALIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS INC · Approved 2015-04-27

Drug application

FDA Application #

ANDA091221

Application type

Abbreviated New Drug Application (Generic)

Brand name

PREGABALIN

Generic name

Pregabalin

Active ingredients

PREGABALIN

Dosage form

CAPSULE

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

WATSON LABS INC

First approval

2015-04-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown